152.15
+2.00
+(1.33%)
At close: January 31 at 9:34:10 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
63,345.00
-88,804.00
-100,569.00
-47,938.00
-26,083.00
Investing Cash Flow
-89,821.00
82,638.00
-114,083.00
-226,770.00
-11,181.00
Financing Cash Flow
27,205.00
202,750.00
35,347.00
347,685.00
118,019.00
End Cash Position
373,970.00
358,328.00
161,900.00
341,246.00
268,269.00
Capital Expenditure
-5,284.00
-11,799.00
-52,979.00
-68,336.00
-14,843.00
Issuance of Capital Stock
43,783.00
203,499.00
35,996.00
355,645.00
118,019.00
Free Cash Flow
58,061.00
-100,603.00
-153,548.00
-116,274.00
-40,926.00
12/31/2020 - 11/7/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NBTX Nanobiotix S.A.
3.4850
-1.83%
NXTC NextCure, Inc.
0.8048
+0.73%
XNCR Xencor, Inc.
18.28
-1.19%
BCAX Bicara Therapeutics Inc.
12.62
-2.25%
SANN.SW Santhera Pharmaceuticals Holding AG
17.12
+4.39%
BCYC Bicycle Therapeutics plc
13.39
+4.86%
XLO Xilio Therapeutics, Inc.
0.7050
+1.45%
ZBIO Zenas BioPharma, Inc.
8.02
+5.25%
TSVT 2seventy bio, Inc.
2.6600
+1.53%
IDYA IDEAYA Biosciences, Inc.
24.35
+1.97%